Current Issue: September–October 2011

NEW in this issue!
A dedicated section on alcohol- and other drug-related HIV/HCV research

Interventions

• Efficacy of Alcohol Brief Intervention in Primary Care by Nonphysicians
• Electronic Self-Help Interventions for Adults with Unhealthy Alcohol Use Moderately Reduce Drinking
• Alcohol and Other Drug Use Decreased During a Statewide Screening and Brief Intervention Program
• Adding Gabapentin to Naltrexone for Alcohol Dependence: No Improvement in Longer Term Outcomes
• No Clear Evidence on How Best to Manage Insomnia in People with Alcohol Dependence

Assessments

• Benzodiazepine Use among Patients Receiving Methadone Maintenance
• One in 12 US College Students Report K2 Use

Health Outcomes

• Patients with Amphetamine Use Disorders Are More Likely to Be Hospitalized or Die from Parkinson’s Disease
• Type of Alcoholic Beverage Consumed Affects Acute Pancreatitis Risk

HIV and HCV

• Naltrexone Has Little, If Any, Liver Toxicity in HIV-Infected Patients and Does Not Adversely Affect HIV Biomarkers
• Behavioral Intervention Associated with Improved Liver Enzymes in HCV-infected Young People Who Use Injection Drugs
• Combination of Substance Use Treatment and Risk Reduction Most Effective at Preventing HCV Seroconversion in People who Inject Drugs
• Counseling and Case Management Increases Eligibility for HCV Treatment

Slide Presentations

• Update on Alcohol, Other Drugs, and Health
• Journal Club

Read Full Newsletter (PDF)